172 related articles for article (PubMed ID: 12091135)
1. Mixed chimerism after bone marrow transplantation for thalassemia major.
Li CK; Chik KW; Tsang KS; Pong H; Shing MM; Yuen PM
Haematologica; 2002 Jul; 87(7):781-2. PubMed ID: 12091135
[TBL] [Abstract][Full Text] [Related]
2. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
Lisini D; Zecca M; Giorgiani G; Montagna D; Cristantielli R; Labirio M; Grignani P; Previderè C; Di Cesare-Merlone A; Amendola G; Bergami E; Mastronuzzi A; Maccario R; Locatelli F
Haematologica; 2008 Dec; 93(12):1859-67. PubMed ID: 18945748
[TBL] [Abstract][Full Text] [Related]
3. FISH analysis of native smears from bone marrow and blood for the monitoring of chimerism and clonal markers after stem cell transplantation in children.
Fuehrer M; Gerusel-Bleck M; Konstantopoulos N; Bender-Goetze C; Walther JU
Int J Mol Med; 2005 Feb; 15(2):291-7. PubMed ID: 15647846
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation.
Andreani M; Nesci S; Lucarelli G; Tonucci P; Rapa S; Angelucci E; Persini B; Agostinelli F; Donati M; Manna M
Bone Marrow Transplant; 2000 Feb; 25(4):401-4. PubMed ID: 10723583
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic stem cell transplantation for beta-thalassemia major: experience in south of Iran.
Ramzi M; Nourani H; Zakernia M; Hamidian Jahromi AR
Transplant Proc; 2004 Oct; 36(8):2509-10. PubMed ID: 15561298
[TBL] [Abstract][Full Text] [Related]
6. [Application of sequential and quantitative monitoring of chimerism in allogeneic hematopoietic stem cell transplantation].
Tang XW; Wu DP; Zhu ZL; Wang W; Sun AN; Qiu HY; Fu ZZ; Chang WR; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):78-81. PubMed ID: 14990044
[TBL] [Abstract][Full Text] [Related]
7. Rapid and complete donor chimerism after unrelated mismatched cord blood transplantation in 5 children with beta-thalassemia major.
Jaing TH; Hung IJ; Yang CP; Chen SH; Sun CF; Chow R
Biol Blood Marrow Transplant; 2005 May; 11(5):349-53. PubMed ID: 15846288
[TBL] [Abstract][Full Text] [Related]
8. Hemopoietic chimerism following stem cell transplantation.
McCann SR; Crampe M; Molloy K; Lawler M
Transfus Apher Sci; 2005 Feb; 32(1):55-61. PubMed ID: 15737874
[TBL] [Abstract][Full Text] [Related]
9. Use of the gel test to follow up chimerism in ABO mismatched bone marrow transplantation patient: a case report.
Lumkul R; Nathalang O; Arnutti P; Janyatham A; Torcharus K; Krutvecheo T; Sriphaisal T
J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S311-6. PubMed ID: 16858974
[TBL] [Abstract][Full Text] [Related]
10. Unexpected complications after bone marrow transplantation in transfusion-dependent children.
Saunders EF; Olivieri N; Freedman MH
Bone Marrow Transplant; 1993; 12 Suppl 1():88-90. PubMed ID: 8374573
[TBL] [Abstract][Full Text] [Related]
11. Nonmyeloablative stem cell transplantation with a haploidentical donor in a class 3 lucarelli severe thalassemia patient.
Hongeng S; Pakakasama S; Chaisiripoomkere W; Ungkanont A; Jootar S
Bone Marrow Transplant; 2004 Aug; 34(3):271-2. PubMed ID: 15170161
[No Abstract] [Full Text] [Related]
12. Paediatric allogeneic bone marrow transplantation for homozygous beta-thalassaemia, the Dutch experience.
Ball LM; Lankester AC; Giordano PC; van Weel MH; Harteveld CL; Bredius RG; Smiers FJ; Egeler RM; Vossen JM
Bone Marrow Transplant; 2003 Jun; 31(12):1081-7. PubMed ID: 12796787
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences.
Koldehoff M; Steckel NK; Hlinka M; Beelen DW; Elmaagacli AH
Am J Hematol; 2006 Oct; 81(10):735-46. PubMed ID: 16838323
[TBL] [Abstract][Full Text] [Related]
14. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
[TBL] [Abstract][Full Text] [Related]
15. Switch from beta-thalassemia major to beta-thalassemia intermedia after secondary graft failure.
Mellouli F; Ksouri H; Lakhal A; Torjmen L; Abdelkefi A; Ladeb S; Hmida S; Othman TB; Béjaoui M
Exp Clin Transplant; 2010 Sep; 8(3):269-71. PubMed ID: 20716049
[TBL] [Abstract][Full Text] [Related]
16. Murine and math models for the level of stable mixed chimerism to cure beta-thalassemia by nonmyeloablative bone marrow transplantation.
Roberts C; Kean L; Archer D; Balkan C; Hsu LL
Ann N Y Acad Sci; 2005; 1054():423-8. PubMed ID: 16339691
[TBL] [Abstract][Full Text] [Related]
17. Complete substitution of cyclophosphamide by fludarabine and ATG in a busulfan-based preparative regimen for children and adolescents with beta-thalassemia.
Sauer M; Bettoni C; Lauten M; Ghosh A; Rehe K; Grigull L; Beilken A; Welte K; Sykora KW
Bone Marrow Transplant; 2005 Sep; 36(5):383-7. PubMed ID: 15995711
[TBL] [Abstract][Full Text] [Related]
18. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA.
Lawler M; McCann SR; Marsh JC; Ljungman P; Hows J; Vandenberghe E; O'Riordan J; Locasciulli A; Socié G; Kelly A; Schrezenmeier H; Marin P; Tichelli A; Passweg JR; Dickenson A; Ryan J; Bacigalupo A;
Br J Haematol; 2009 Mar; 144(6):933-45. PubMed ID: 19183198
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
Bartsch K; Al-Ali H; Reinhardt A; Franke C; Hudecek M; Kamprad M; Tschiedel S; Cross M; Niederwieser D; Gentilini C
Transplantation; 2009 Jan; 87(2):217-21. PubMed ID: 19155975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]